An increasing no. of business organisations are now selling cannabidiol (CBD) products in the mid-South, with even the large business chains becoming a part of the trend. However, the healthcare experts are not still sure if such products perform as they are advertised.
CBD, a chemical compound which is found in marijuana and does not leave a person feeling intoxicated, is promoted to treat medical conditions like chronic pain, anxiety, insomnia, depression and several others. However, the FDA hasn’t approved any of these treatments, meaning that the science pertaining to CBD isn’t still clear.
Megan Mulligan from the Tennessee Health Science Center University has researched about the effects cannabinoids like CBD have. According to Mulligan, a few people claim to have received major benefits when they used CBD products and many clinical settings have shown the therapeutic qualities it has. But still, there is no proven guarantee that such products really comprise of what’s being advertised.
The CBD products aren’t FDA-regulated, thus one cannot be sure, she said. Though CBD generally does not pose a real threat, there are other harmful ingredients which could be mixed with the product that a person purchases from a store.
While retail CBD-based products can be available with proper lab analysis, further research is still required before the doctors could prescribe CBD confidently, Mulligan added.
Mulligan hopes that research would pace up soon and healthcare experts will better know about the benefits as well as disadvantages of CBD.